vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and First Foundation Inc. (FFWM). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $48.4M, roughly 1.3× First Foundation Inc.). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -97.9%, a 26.9% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-35.2M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -2.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.
CTKB vs FFWM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $48.4M |
| Net Profit | $-44.1M | $-8.0M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -97.5% |
| Net Margin | -70.9% | -97.9% |
| Revenue YoY | 8.1% | 421.7% |
| Net Profit YoY | -557.1% | 43.0% |
| EPS (diluted) | — | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $48.4M | ||
| Q3 25 | $52.3M | $63.6M | ||
| Q2 25 | $45.6M | $51.4M | ||
| Q1 25 | $41.5M | $71.4M | ||
| Q4 24 | $57.5M | $9.3M | ||
| Q3 24 | $51.5M | $9.2M | ||
| Q2 24 | $46.6M | $57.5M | ||
| Q1 24 | $44.9M | $51.1M |
| Q4 25 | $-44.1M | $-8.0M | ||
| Q3 25 | $-5.5M | $-146.3M | ||
| Q2 25 | $-5.6M | $-7.7M | ||
| Q1 25 | $-11.4M | $6.9M | ||
| Q4 24 | $9.6M | $-14.1M | ||
| Q3 24 | $941.0K | $-82.2M | ||
| Q2 24 | $-10.4M | $3.1M | ||
| Q1 24 | $-6.2M | $793.0K |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -97.5% | ||
| Q3 25 | -17.6% | -92.7% | ||
| Q2 25 | -23.3% | -21.1% | ||
| Q1 25 | -36.1% | 8.8% | ||
| Q4 24 | 5.2% | -247.7% | ||
| Q3 24 | -8.2% | -1276.7% | ||
| Q2 24 | -18.3% | 4.6% | ||
| Q1 24 | -23.9% | -0.2% |
| Q4 25 | -70.9% | -97.9% | ||
| Q3 25 | -10.5% | -230.1% | ||
| Q2 25 | -12.2% | -15.0% | ||
| Q1 25 | -27.5% | 9.7% | ||
| Q4 24 | 16.8% | -152.2% | ||
| Q3 24 | 1.8% | -896.9% | ||
| Q2 24 | -22.4% | 5.4% | ||
| Q1 24 | -13.8% | 1.6% |
| Q4 25 | — | $-0.09 | ||
| Q3 25 | — | $-1.78 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $-0.24 | ||
| Q3 24 | — | $-1.23 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $1.6B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $912.6M |
| Total Assets | $461.5M | $11.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $1.6B | ||
| Q3 25 | $93.3M | $1.7B | ||
| Q2 25 | $75.5M | $1.1B | ||
| Q1 25 | $95.3M | $1.0B | ||
| Q4 24 | $98.7M | $1.0B | ||
| Q3 24 | $162.3M | $1.1B | ||
| Q2 24 | $177.9M | $1.4B | ||
| Q1 24 | $168.8M | $1.6B |
| Q4 25 | $341.7M | $912.6M | ||
| Q3 25 | $378.6M | $917.9M | ||
| Q2 25 | $377.6M | $1.1B | ||
| Q1 25 | $379.6M | $1.1B | ||
| Q4 24 | $395.7M | $1.1B | ||
| Q3 24 | $385.5M | $1.1B | ||
| Q2 24 | $389.1M | $933.2M | ||
| Q1 24 | $392.6M | $928.7M |
| Q4 25 | $461.5M | $11.9B | ||
| Q3 25 | $494.9M | $11.9B | ||
| Q2 25 | $493.3M | $11.6B | ||
| Q1 25 | $482.6M | $12.6B | ||
| Q4 24 | $499.5M | $12.6B | ||
| Q3 24 | $491.2M | $13.4B | ||
| Q2 24 | $483.7M | $13.7B | ||
| Q1 24 | $492.1M | $13.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-31.9M |
| Free Cash FlowOCF − Capex | $-1.8M | $-35.2M |
| FCF MarginFCF / Revenue | -2.9% | -72.8% |
| Capex IntensityCapex / Revenue | 1.6% | 6.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-45.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-31.9M | ||
| Q3 25 | $-3.9M | $9.2M | ||
| Q2 25 | $108.0K | $-16.3M | ||
| Q1 25 | $-125.0K | $-552.0K | ||
| Q4 24 | $2.0M | $-8.7M | ||
| Q3 24 | $13.2M | $14.2M | ||
| Q2 24 | $6.2M | $-9.1M | ||
| Q1 24 | $4.0M | $7.2M |
| Q4 25 | $-1.8M | $-35.2M | ||
| Q3 25 | $-4.6M | $8.6M | ||
| Q2 25 | $-1.5M | $-16.7M | ||
| Q1 25 | $-974.0K | $-2.5M | ||
| Q4 24 | $1.1M | $-11.4M | ||
| Q3 24 | $12.2M | $13.4M | ||
| Q2 24 | $5.2M | $-9.4M | ||
| Q1 24 | $3.4M | $5.9M |
| Q4 25 | -2.9% | -72.8% | ||
| Q3 25 | -8.7% | 13.5% | ||
| Q2 25 | -3.2% | -32.4% | ||
| Q1 25 | -2.3% | -3.5% | ||
| Q4 24 | 1.9% | -123.5% | ||
| Q3 24 | 23.7% | 146.2% | ||
| Q2 24 | 11.0% | -16.3% | ||
| Q1 24 | 7.6% | 11.6% |
| Q4 25 | 1.6% | 6.9% | ||
| Q3 25 | 1.3% | 1.0% | ||
| Q2 25 | 3.5% | 0.8% | ||
| Q1 25 | 2.0% | 2.8% | ||
| Q4 24 | 1.6% | 29.4% | ||
| Q3 24 | 2.0% | 9.0% | ||
| Q2 24 | 2.3% | 0.4% | ||
| Q1 24 | 1.3% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | -2.96× | ||
| Q1 24 | — | 9.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FFWM
Segment breakdown not available.
